Furthermore, our observations through IHC staining indicated that MZ1 treatment significantly inhibited the expression of BRD4 and the proliferation marker Ki-67 in tumor tissues, in comparison to the control group (Fig. 5e). The gene discussed is MKI67; the disease is neoplasm.